POAI logo

Predictive Oncology (POAI) Cash From Operations

Annual CFO

-$13.19 M
-$818.60 K-6.62%

December 31, 2023


Summary


Performance

POAI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPOAIcash flowmetrics:

Quarterly CFO

-$2.28 M
+$938.60 K+29.17%

September 30, 2024


Summary


Performance

POAI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPOAIcash flowmetrics:

TTM CFO

-$13.04 M
-$221.20 K-1.73%

September 30, 2024


Summary


Performance

POAI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPOAIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

POAI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.6%+29.2%-1.7%
3 y3 years-7.6%+36.2%-0.8%
5 y5 years-149.4%+36.2%-0.8%

POAI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.0%at low-10.8%+44.8%-8.9%+1.1%
5 y5-year-51.0%at low-10.8%+44.8%-49.4%+1.1%
alltimeall time-1507.1%at low<-9999.0%+48.5%-3776.0%+1.1%

Predictive Oncology Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.28 M(-29.2%)
-$13.04 M(+1.7%)
Jun 2024
-
-$3.22 M(-5.8%)
-$12.82 M(-2.7%)
Mar 2024
-
-$3.42 M(-17.3%)
-$13.18 M(-0.1%)
Dec 2023
-$13.19 M(+6.6%)
-$4.13 M(+100.6%)
-$13.19 M(+7.3%)
Sep 2023
-
-$2.06 M(-42.4%)
-$12.30 M(-5.0%)
Jun 2023
-
-$3.57 M(+4.3%)
-$12.95 M(+1.9%)
Mar 2023
-
-$3.43 M(+6.0%)
-$12.70 M(+2.7%)
Dec 2022
-$12.37 M(+1.3%)
-$3.23 M(+19.5%)
-$12.37 M(-4.0%)
Sep 2022
-
-$2.71 M(-18.8%)
-$12.88 M(-1.8%)
Jun 2022
-
-$3.33 M(+7.8%)
-$13.11 M(+9.4%)
Mar 2022
-
-$3.09 M(-17.4%)
-$11.98 M(-1.9%)
Dec 2021
-$12.21 M(-0.4%)
-$3.74 M(+27.4%)
-$12.21 M(+13.4%)
Sep 2021
-
-$2.94 M(+33.2%)
-$10.77 M(-2.7%)
Jun 2021
-
-$2.20 M(-33.6%)
-$11.06 M(-12.2%)
Mar 2021
-
-$3.32 M(+44.2%)
-$12.61 M(+2.8%)
Dec 2020
-$12.26 M(+40.4%)
-$2.30 M(-28.7%)
-$12.26 M(-3.9%)
Sep 2020
-
-$3.23 M(-13.8%)
-$12.75 M(+11.8%)
Jun 2020
-
-$3.75 M(+26.1%)
-$11.41 M(+18.1%)
Mar 2020
-
-$2.97 M(+6.3%)
-$9.66 M(+10.6%)
Dec 2019
-$8.73 M(+65.1%)
-$2.80 M(+47.8%)
-$8.73 M(+22.0%)
Sep 2019
-
-$1.89 M(-5.3%)
-$7.16 M(+14.9%)
Jun 2019
-
-$2.00 M(-2.5%)
-$6.23 M(+10.3%)
Mar 2019
-
-$2.05 M(+68.2%)
-$5.64 M(+6.7%)
Dec 2018
-$5.29 M(+18.6%)
-$1.22 M(+26.6%)
-$5.29 M(-1.9%)
Sep 2018
-
-$962.20 K(-31.9%)
-$5.39 M(-1.9%)
Jun 2018
-
-$1.41 M(-16.6%)
-$5.50 M(+10.0%)
Mar 2018
-
-$1.69 M(+28.1%)
-$5.00 M(+12.1%)
Dec 2017
-$4.46 M(+1.8%)
-$1.32 M(+24.0%)
-$4.46 M(+16.9%)
Sep 2017
-
-$1.07 M(+16.6%)
-$3.81 M(+4.0%)
Jun 2017
-
-$914.60 K(-20.9%)
-$3.67 M(-7.1%)
Mar 2017
-
-$1.16 M(+70.8%)
-$3.95 M(-9.9%)
Dec 2016
-$4.38 M
-$677.10 K(-26.4%)
-$4.38 M(-33.2%)
DateAnnualQuarterlyTTM
Sep 2016
-
-$919.70 K(-23.1%)
-$6.55 M(-34.8%)
Jun 2016
-
-$1.20 M(-24.6%)
-$10.06 M(+10.9%)
Mar 2016
-
-$1.59 M(-44.3%)
-$9.07 M(+21.1%)
Dec 2015
-$7.49 M(+122.1%)
-$2.85 M(-35.6%)
-$7.49 M(+53.9%)
Sep 2015
-
-$4.42 M(+2012.1%)
-$4.87 M(+197.0%)
Jun 2015
-
-$209.40 K(+3926.9%)
-$1.64 M(+0.9%)
Mar 2015
-
-$5200.00(-97.7%)
-$1.62 M(-51.8%)
Dec 2014
-$3.37 M(-12.5%)
-$228.70 K(-80.9%)
-$3.37 M(-7.9%)
Sep 2014
-
-$1.20 M(+512.9%)
-$3.66 M(-0.5%)
Jun 2014
-
-$195.00 K(-88.9%)
-$3.68 M(-21.2%)
Mar 2014
-
-$1.75 M(+237.6%)
-$4.67 M(+21.1%)
Dec 2013
-$3.86 M(+225.6%)
-$519.00 K(-57.2%)
-$3.86 M(+3.1%)
Sep 2013
-
-$1.21 M(+2.6%)
-$3.74 M(+40.4%)
Jun 2013
-
-$1.18 M(+25.8%)
-$2.66 M(+42.1%)
Mar 2013
-
-$940.30 K(+133.0%)
-$1.87 M(+58.3%)
Dec 2012
-$1.18 M(-33.5%)
-$403.50 K(+195.4%)
-$1.18 M(-14.0%)
Sep 2012
-
-$136.60 K(-65.3%)
-$1.38 M(-14.9%)
Jun 2012
-
-$393.90 K(+57.4%)
-$1.62 M(-2.8%)
Mar 2012
-
-$250.20 K(-58.0%)
-$1.66 M(-6.6%)
Dec 2011
-$1.78 M(+117.1%)
-$595.70 K(+57.6%)
-$1.78 M(+44.4%)
Sep 2011
-
-$378.10 K(-14.1%)
-$1.23 M(+13.2%)
Jun 2011
-
-$440.40 K(+19.9%)
-$1.09 M(+22.1%)
Mar 2011
-
-$367.40 K(+671.8%)
-$892.80 K(+8.8%)
Dec 2010
-$820.70 K(-37.4%)
-$47.60 K(-79.7%)
-$820.70 K(-25.2%)
Sep 2010
-
-$234.60 K(-3.5%)
-$1.10 M(-3.9%)
Jun 2010
-
-$243.20 K(-17.6%)
-$1.14 M(-10.0%)
Mar 2010
-
-$295.30 K(-9.0%)
-$1.27 M(-3.1%)
Dec 2009
-$1.31 M(+45.5%)
-$324.50 K(+16.5%)
-$1.31 M(+32.9%)
Sep 2009
-
-$278.60 K(-24.8%)
-$985.50 K(+39.4%)
Jun 2009
-
-$370.40 K(+10.1%)
-$706.90 K(+110.1%)
Mar 2009
-
-$336.50 K
-$336.50 K
Dec 2008
-$900.50 K
-
-

FAQ

  • What is Predictive Oncology annual cash flow from operations?
  • What is the all time high annual CFO for Predictive Oncology?
  • What is Predictive Oncology annual CFO year-on-year change?
  • What is Predictive Oncology quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Predictive Oncology?
  • What is Predictive Oncology quarterly CFO year-on-year change?
  • What is Predictive Oncology TTM cash flow from operations?
  • What is the all time high TTM CFO for Predictive Oncology?
  • What is Predictive Oncology TTM CFO year-on-year change?

What is Predictive Oncology annual cash flow from operations?

The current annual CFO of POAI is -$13.19 M

What is the all time high annual CFO for Predictive Oncology?

Predictive Oncology all-time high annual cash flow from operations is -$820.70 K

What is Predictive Oncology annual CFO year-on-year change?

Over the past year, POAI annual cash flow from operations has changed by -$818.60 K (-6.62%)

What is Predictive Oncology quarterly cash flow from operations?

The current quarterly CFO of POAI is -$2.28 M

What is the all time high quarterly CFO for Predictive Oncology?

Predictive Oncology all-time high quarterly cash flow from operations is -$5200.00

What is Predictive Oncology quarterly CFO year-on-year change?

Over the past year, POAI quarterly cash flow from operations has changed by +$938.60 K (+29.17%)

What is Predictive Oncology TTM cash flow from operations?

The current TTM CFO of POAI is -$13.04 M

What is the all time high TTM CFO for Predictive Oncology?

Predictive Oncology all-time high TTM cash flow from operations is -$336.50 K

What is Predictive Oncology TTM CFO year-on-year change?

Over the past year, POAI TTM cash flow from operations has changed by -$221.20 K (-1.73%)